1. India Stocks

  2. •

    Basic Materials

  3. •

    Agricultural Inputs
Heranba Industries Limited

Heranba Industries Limited

HERANBA.NS
Heranba Industries LimitedIN flagNational Stock Exchange of India
178.49
INR
+0.08
- -
7.14BMarket Cap
Heranba Industries Limited
HERANBA.NS
(National Stock Exchange of India)

Recent

price

178.49

P/E

ratio

- -

div

yld

- -

ROIC.AI

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
129.87
130.05
149.24
184.48
248.16
233.49
307.11
358.64
327.7
312.04
350.45
400.16
Revenue per Share
4.59
4.17
4.93
11.71
18.84
24.41
39.4
47.25
26.08
8.72
0.77
-14.84
Basic EPS, GAAP
1.91
2.34
5.9
12.98
21.92
1.57
9.27
4.39
15.29
-36.57
-43.65
- -
Free Cash Flow per Basic Share
0.64
0.74
0.35
1.53
1.18
1.18
1.5
0.7
2
1.25
1.25
- -
Dividend per Share
14.51
19
22
30.9
49.17
71.08
109.6
152.28
176.24
183.71
183.15
- -
Book Value per Share
21.21
24.86
29.1
39.32
57.02
80.19
134.93
178.57
202.52
213.19
212.41
- -
Tangible Book Value per Share
40
40
40
40
40
40
39
40
40
40
40
40
Basic Weighted Avg Shares
5,197
5,204
5,971
7,382
9,930
9,343
12,020
14,349
13,112
12,486
14,023
16,028
Sales/Revenue/Turnover
7.96
8
8.43
11.22
12.63
12.97
17.19
16.74
10.24
4.14
2.95
-0.63
Operating Margin (%)
53
40
40
50
60
82
147
198
226
261
566
882
Depreciation Expense
184
167
198
469
754
977
1,542
1,891
1,044
349
31
-594
Net Income, GAAP
37.19
42.48
42.74
38.57
38.26
24.2
25.95
25.93
24.14
33.96
87.54
170.81
Effective Tax Rate (%)
3.54
3.21
3.31
6.35
7.59
10.45
12.83
13.18
7.96
2.79
0.22
-3.71
Profit Margin (%)
501
529
685
906
1,296
1,760
3,680
5,001
5,048
2,414
1,730
- -
Working Capital
6
4
2
3
- -
2
12
6
35
215
960
- -
LT Debt
851
997
1,167
1,573
2,282
3,208
5,281
7,145
8,104
8,531
8,499
- -
Total Equity
- -
13.93
16.22
25.44
31.39
29.73
33.51
27.9
12.72
3.59
0.47
- -
Return on Invested Capital (%)
- -
15.34
15.58
29.08
36.75
36.33
39.11
33.57
14.95
4.93
0.72
6.97
Return on Capital (%)
- -
24.87
24.05
44.29
47.07
40.59
43.24
36.42
15.88
4.84
0.42
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Jun'26
Sep'26
Dec'26
ST Debt
- -
4,162
- -
LT Borrowings
- -
933
- -
LT Finance Leases
- -
31
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
- -
40
- -
Market Capitalization
13,686
11,739
9,906

Working Capital

FRC

•

in mil. unless spec.
Jun'26
Sep'26
Dec'26
Total Current Assets
- -
13,864
- -
Cash, Cash Equivalents & STI
- -
430
- -
Accounts Receivable, Net
- -
7,464
- -
Inventories
- -
4,959
- -
Total Current Liabilities
- -
12,295
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
4,162
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
27.29%
23.64%
-0.37%
Free Cash Flow
62.52%
70.91%
19.38%
Net Income, GAAP
11.45%
-24.41%
-91.2%
Sales/Revenue/Turnover
11.41%
9.39%
12.31%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2,752
4,243
2,997
2,494
12,486
2025
2,962
4,374
3,413
3,273
14,023
2026
4,524
5,217
3,014
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-1.4
6.73
3.48
- -
8.72
2025
4.19
9.49
-2.55
- -
0.77
2026
1.53
-0.36
-5.81
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
1.25
2025
- -
- -
- -
- -
1.25
2026
- -
- -
- -
- -
- -
Similar Companies
Modi Naturals Limited (MODINATUR.BO)
Bagfas Bandirma Gubre Fabrikalari A.S. (BAGFS.IS)
NACL Industries Limited (NACLIND.NS)
SBEC Sugar Limited (SBECSUG.BO)
Chambal Fertilisers and Chemicals Limited (CHAMBLFERT.NS)
Guizhou Chitianhua Co., Ltd. Class A (600227.SS)
Business
Heranba Industries Limited is an Indian agrochemical company primarily engaged in manufacturing synthetic pyrethroids and their intermediates. Founded in 1992 and headquartered in Vapi, Gujarat, the company operates fully integrated and modern manufacturing facilities in the industrial belts of Vapi and Sarigam, with an upcoming site at Saykha. Its core product portfolio includes insecticides, herbicides, fungicides, plant growth regulators, and public health products such as general insect control, larvae and vector control, termite control, fogging, and indoor residual spray, alongside fertilizers. The company serves both domestic and international markets, targeting agricultural and public health sectors. Heranba operates an in-house research and development facility focused on innovative product development and process intensification to deliver advanced agrochemical solutions. It emphasizes sustainable practices, including effluent treatment, hazardous waste management, and health and safety standards. The company's products are marketed under various proprietary brands and formulations, supporting crop productivity and public health improvements. Recent developments include the receipt of environmental clearance for manufacturing expansion at its Sarigam plant. The company has actively pursued new product registrations in domestic and export markets, aiming to broaden its product portfolio and expand its customer base. In fiscal year 2024, despite challenges from global economic conditions and sluggish demand in key export regions, Heranba continued to grow its formulation business and strengthen its distribution network to drive future revenue growth. The company views fiscal year 2025 as a critical period for accelerating growth and margin expansion through focused productivity improvements and portfolio diversification. Heranba Industries Limited operates primarily in the pesticides and agrochemical industry, serving farmers and public health authorities across India and international markets. With nearly three decades of operations, it holds a strong position as one of the largest manufacturers of synthetic pyrethroids in India, maintaining a strategic focus on innovation and sustainable development within the agrochemical sector. The company is publicly listed on the NSE under the ticker HERANBA.NS and sustains a significant promoter holding. It continues to leverage its manufacturing capabilities and R&D infrastructure to enhance product offerings and meet evolving market demands.